VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_21-vv-01914
Package ID: USCOURTS-cofc-1_21-vv-01914
Petitioner: Kevin Slayton
Filed: 2021-09-27
Decided: 2025-05-02
Vaccine: influenza
Vaccination date: 2018-09-27
Condition: Guillain-Barre Syndrome
Outcome: compensated
Award amount USD: 25000

AI-assisted case summary:
On September 27, 2021, Kevin Slayton filed a petition under the National Vaccine Injury Compensation Program alleging that the influenza vaccine he received on September 27, 2018, caused him to develop Guillain-Barre Syndrome (GBS). The respondent, the Secretary of Health and Human Services, denied that Mr. Slayton sustained GBS or any other injury caused by the vaccine. Despite this denial, the parties filed a stipulation on April 1, 2025, agreeing that a decision should be entered awarding compensation to the petitioner. Special Master Herbrina D.S. Young reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. The stipulation provided for a lump sum payment of $25,000.00 to be paid through an ACH deposit to petitioner's counsel's IOLTA account for prompt disbursement to Mr. Slayton. This amount was stipulated as compensation for all damages available under the program. The decision was issued on May 2, 2025, and judgment was entered accordingly. Petitioner was represented by Howard Spessard Stevens of Pascale Stevens, LLC, and respondent was represented by Jamica Marie Littles of the United States Department of Justice. The public decision does not describe the onset of symptoms, specific clinical details, medical tests, treatments, or expert witnesses.

Theory of causation field:
Petitioner Kevin Slayton alleged that the influenza vaccine administered on September 27, 2018, caused him to develop Guillain-Barre Syndrome (GBS). The respondent denied this allegation. The parties reached a stipulation for compensation, which was adopted by Special Master Herbrina D.S. Young. The stipulation awarded Petitioner $25,000.00 as a lump sum for all damages. The specific medical mechanism, expert testimony, or scientific basis for the alleged causation were not detailed in the public decision, as the case was resolved via stipulation. The decision date was May 2, 2025. Petitioner's counsel was Howard Spessard Stevens, and respondent's counsel was Jamica Marie Littles.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_21-vv-01914-0
Date issued/filed: 2025-05-02
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 4/7/25) regarding 57 DECISION Stipulation/Proffer. Signed by Special Master Herbrina D S Young. (kis) Service on parties made.
--------------------------------------------------------------------------------
Case 1:21-vv-01914-UNJ Document 58 Filed 05/02/25 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: April 7, 2025
* * * * * * * * * * * * * * * * * * * * * * * * *
KEVIN SLAYTON, * No. 21-1914V
*
Petitioner, * Special Master Young
v. *
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * * * * * * * * * * * * * *
Howard Spessard Stevens, Pascale Stevens, LLC, Baltimore, MD, for Petitioner.
Jamica Marie Littles, United States Department of Justice, Washington, DC, for Respondent.
DECISION1
On September 27, 2021, Kevin Slayton (“Petitioner”) filed a petition for compensation
pursuant to the National Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa-10 to -34
(2012). Petitioner alleged that the influenza (“flu”) vaccine he received on September 27, 2018,
caused him to suffer from Guillain-Barre Syndrome (“GBS”). Pet. at 1, ECF No. 1.
On April 1, 2025, the parties filed a stipulation in which they state that a decision should
be entered awarding compensation to Petitioner. Stipulation ¶ 7, ECF No. 56. Respondent “denies
that [P]etitioner sustained GBS; and denies that the flu vaccine caused [P]etitioner any other injury
or [P]etitioner’s current condition.” Id. ¶ 6. Nevertheless, the parties agree to the joint stipulation.
See id. ¶ 7. I find the stipulation reasonable and adopt it as the decision of the Court in awarding
damages, on the terms set forth therein.
1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at
https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act
of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub L. No. 99-660, 100 Stat. 3755.

Case 1:21-vv-01914-UNJ Document 58 Filed 05/02/25 Page 2 of 7
The parties stipulate that Petitioner shall receive the following compensation:
(a) A lump sum of $25,000.00 to be paid through an ACH deposit to
petitioner’s counsel’s IOLTA account for prompt disbursement to
petitioner.
Id. ¶ 8. These amounts represent compensation for all damages that would be available under 42
U.S.C. § 300aa-15(a).
I approve the requested amount for Petitioner’s compensation. Accordingly, an award
should be made consistent with the stipulation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3
IT IS SO ORDERED.
s/Herbrina D.S. Young
Herbrina D.S. Young
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:21-vv-01914-UNJ Document 58 Filed 05/02/25 Page 3 of 7

Case 1:21-vv-01914-UNJ Document 58 Filed 05/02/25 Page 4 of 7

Case 1:21-vv-01914-UNJ Document 58 Filed 05/02/25 Page 5 of 7

Case 1:21-vv-01914-UNJ Document 58 Filed 05/02/25 Page 6 of 7

Case 1:21-vv-01914-UNJ Document 58 Filed 05/02/25 Page 7 of 7